-
At Medlab Middle East 2023, NZYTech's CEO, Pedro Rio, met with valued partners including Biomss and Medical Masar Alshefaa, to discuss the latest updates and explore opportunities to deliver exceptional products and superior solutions.
NZYTech remains committed to driving growth and success through partnerships, delivering quality solutions in life science research and clinical diagnostics to the UAE and the Kingdom of Saudi Arabia. -
Easy-to-use polymerases engineered for fast detection and designed for state-of-the-art applications in molecular biology and diagnostics are key for both life science reasearchers performing critical experiments and technicians carrying out diagnostic testing.
Rita Simões, Junior Scientist at NZYTech’s R&D department, has dedicated her time to an important research and development project at NZYTech - A new NZY Bst DNA polymerase, part of a new generation of DNA polymerases. -
-
Join us at Medlab Middle East, the renowned exhibition for laboratory and medical technologies, to connect with industry leaders, exchange knowledge, and discover the latest innovations in biotech.
Join us at stand Z6-J19. Our team is looking forward to showcasing our latest innovation in Molecular Diagnostics. Our qPCR kits, ranging from SARS-CoV-2 IVD kits to Human Pathogen to Veterinary and Agricultural, provide execptional performance. -
NZYTech is now ISO 13485 certified for the design, development, manufacture and sales of reagents and IVD kits to detect viral infections by Real-Time PCR.
This certification ensures rigorous standards and exemplifies our commitment to effective processes and quality management in the area of qPCR, starting at research and development and ending at it’s manufacturing and sales.
We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.